IPCA Labs total revenues declined by 19% YoY to Rs 7,580 mn (lower than our estimates of Rs 7,941 mn) due to tepid performance of US formulations and CIS formulations. Its operating margins decreased by 1390bps YoY to 10.8% (lower than our estimate of 11.8%) during the quarter due to lower gross margins and higher expenditure.